Verismo Therapeutics, Inc., 2026-05-20
An SEC Form D private-offering notice from Philadelphia, PA, a $28,000,000 filer-stated offering target in Biotech. Filed 2026-05-20. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biotech developing KIR-CAR T cell therapies for solid tumors and blood cancers, founded by Penn Medicine researchers who helped invent Kymriah.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Simple Lending Co, LLC, 2026-05-26, $5M, Carlisle, PA
- beyondGREEN biotech Inc., 2026-05-21, Santa Ana, CA
- Thoroughcare, Inc., 2026-05-21, $2.2M, Pittsburgh, PA
- Reprise Biomedical, Inc., 2026-05-21, $10M, Plymouth, MN
- OxyDial Inc, 2026-05-20, $1.5M, Philadelphia, PA
- Ropana Vascular Inc., 2026-05-20, $1M, Plano, TX
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.